A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy-Reference-Cited by-同舟云学术

A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Published:2014-06-30 Issue:6 Volume:9 Page:e101057
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cheung Chui Ming Gemmy,Li Xiang,Mathur Ranjana,Lee Shu Yen,Chan Choi Mun,Yeo Ian,Loh Boon Kwang,Williams Rachel,Wong Edmund Yick-Mun,Wong Doric,Wong Tien Yin

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Age-related macular degeneration;LS Lim;Lancet,2012

2. Prevalence of age related macular degeneration in 4 racial/ethnic groups in the Multi-ethnic Study of Atherosclerosis;R Klein;Ophthalmology,2006

3. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study;P Mitchell;Ophthalmology,1995

4. The Prevalence of Age-Related Macular Degeneration in Asians;R Kawasaki;Ophthalmology,2010

5. Ranibizumab for neovascular age-related macular degeneration;PJ Rosenfeld;N Eng J Med,2006

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term efficacy and safety of brolucizumab in neovascular age‐related macular degeneration: A multicentre retrospective real‐world study;Acta Ophthalmologica;2024-05-05

2. Twenty‐four‐month real‐life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians;Clinical & Experimental Ophthalmology;2023-10-23

3. Macular neovascularization and polypoidal choroidal vasculopathy: phenotypic variations, pathogenic mechanisms and implications in management;Eye;2023-10-06

4. Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypes;Nature Communications;2023-09-11

5. Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-06-09